www.i-canadianpharmacy.com
- US Toll free:
- Regular US:
- UK:
- Categories list
-
- Alcoholism
- Alzheimer's And Parkinson's
- Analgesics
- Anti-inflammatories
- Antiallergic
- Antibiotics
- Anticonvulsants
- Antidepressants
- Antifungals
- Antiparasitic
- Antivirals
- Arthritis
- Asthma
- Birth Control
- Cancer
- Cardiovascular Diseases
- Cholesterol
- Diabetes
- Diuretics
- Erectile Dysfunction
- Eye Care
- Gastrointestinal Tract
- HIV
- Hypertension
- Men's Health
- Mental Disorders
- Migraine
- Muscle Relaxants
- Neurological Disorders
- Obesity
- Osteoporosis
- Respiratory Tract
- Skin Care
- Surgery
- Urinary Tract
- Women's Health
Generic Dipyridamole - Aggrenox, Persantine
Generic Aggrenox
Generic Aggrenox is used for reducing the risk of stroke in patients who have previously had a stroke due to a blood clot in the brain. It is also used to reduce the risk of stroke in patients who have had transient ischemic attacks (TIAs).
$0.96
Buy now!
Generic Persantine
Evaluating coronary artery disease in patients who cannot exercise adequately before thallium imaging (cardiac...
$0.60
Buy now!
Choose Your language:
- Testimonials
-
Thank you very much for your quick delivery. I already received my order about one week before. Thank you very much again for your kindly corporation. Best regards - Yukio
Read more »
- News
-
- FDA approved Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
- Considering the information of three randomized, multicenter, double, blind clinical studies and a retrospective analysis of the medical documentation, FDA approved on October 7, 2011 Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years
- The forming, development and monitoring of the pharmaceutical market in USA in September 2011
- In spite of low rates and stagnation of industrial development, the pharmaceutical market shows a dynamical growth
- Sildenafil citrate and pulmonary arterial hypertension
- Pulmonary arterial hypertension Definition “pulmonary arterial hypertension” is related to a group of diseases characterized by: - Progressive increase in pulmonary vascular resistance; - Reduction in pulmonary bloodflow; - High pulmonary artery pressure; - Contractility of the heart right ventricle; - Right ventricular failure
- Fruit and vegetables do not reduce overall cancer risk, review concludes
- Eating lots of fruit and vegetables will do little to reduce your risk of developing cancer, according to a review of a decade of research involving more than a million people
- Common painkillers could be linked to male reproductive disorder
- The use of mild painkillers, such as paracetamol, in pregnancy – previously considered harmless to the baby in the womb – could be a major factor in the rise of male reproductive disorders, according to a study
-
- Ministroke needs quick treatment - STLtoday.com
- Ministroke needs quick treatmentSTLtoday
- The impact of aging and atherosclerotic risk factors on transthoracic coronary ... - 7thSpace Interactive (press release)
- The impact of aging and atherosclerotic risk factors on transthoracic coronary
- Medication errors in patients with dysphagia - Nursing Times
- Medication errors in patients with dysphagiaNursing TimesThe wrong formulation category included eight incidences of patients inappropriately chewing medicines such as modified-release dipyridamole (six patients chewed this, just fewer than 1% of patients observed)
- Fish Oil and Hemodialysis Graft Patency - Journal of American Medical Association (subscription)
- Fish Oil and Hemodialysis Graft PatencyJournal of American Medical Association (subscription)A prior large, randomized, placebo-controlled trial (ie, the DAC Graft Trial) found that sustained-release dipyridamole plus low-dose aspirin modestly prolonged primary unassisted patency of new hemodialysis grafts
 |
Bookmark this site |
|---|
 |
Subscribe to the News |
|---|
